# Investor om Novos vækstjagt: Vejen er farlig Page: https://stenobird.com/podcast/b-rsen-investor-6986380/investor-om-novos-v-kstjagt-vejen-er-farlig Text version: https://stenobird.com/podcast/b-rsen-investor-6986380/investor-om-novos-v-kstjagt-vejen-er-farlig.md Podcast: [Børsen investor](https://stenobird.com/podcast/b-rsen-investor-6986380) Published: 2026-08-05T09:28:00+00:00 Episode link: https://pod.space/borseninvestor/5-august Audio file: https://media.pod.space/borseninvestor/investor-05082026_260805.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/b-rsen-investor-6986380/episodes/investor-om-novos-v-kstjagt-vejen-er-farlig Duration seconds: 3426 ## Resource Novo Nordisk straffes på sit halvårsregnskab. Hør hvorfor i denne Børsen Investor podcast, hvor investor Ole Søeberg, aktiestrateg for kapitalforvalteren Brock Milton Capital, fortæller, hvorfor Novos strategi til mere vækst er en farefuld vej at gå. Henrik Karlsen, investeringsdirektør i investeringsfonden Horizon3, medvirker også og giver sit syn på sommerens mange voldsomme kursbevægelser inden for teknologi-segmentet og fortæller, hvorfor han holder fast i en aktie som Palantir. Værter: Gro Høyer Thielst og investorredaktør Simon Kirketerp Producer: Frederik Præstiin Følg All Star porteføljen her: https://borsen.dk/investor/all-stars-portefoelje/4318eb37-8a86-4d71-a3d1-2fc9ccbd5c18/all-star-portefoljen ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/b-rsen-investor-6986380/episodes/investor-om-novos-v-kstjagt-vejen-er-farlig/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/b-rsen-investor-6986380/investor-om-novos-v-kstjagt-vejen-er-farlig.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.